Alzinova AB (publ) (STO:ALZ)
Sweden · Delayed Price · Currency is SEK 0.4540
-0.0260 (-5.42%)
Apr 24, 2026, 5:05 PM CET
Alzinova AB Revenue
In the year 2025, Alzinova AB had annual revenue of 26.80M SEK with 59.44% growth. Alzinova AB had revenue of 5.99M in the quarter ending December 31, 2025, with 13.00% growth.
Revenue
26.80M
Revenue Growth
+59.44%
P/S Ratio
2.62
Revenue / Employee
5.36M
Employees
5
Market Cap
70.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.80M | 9.99M | 59.44% |
| Dec 31, 2024 | 16.81M | -3.06M | -15.41% |
| Dec 31, 2023 | 19.87M | 3.24M | 19.49% |
| Dec 31, 2022 | 16.63M | -688.74K | -3.98% |
| Dec 31, 2021 | 17.32M | 2.42M | 16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 287.55M |
| Nanologica AB | 21.13M |
| Scandinavian ChemoTech AB | 12.29M |
| Biovica International AB | 10.93M |
| AcouSort AB | 10.43M |
| Spago Nanomedical AB | 4.82M |
| OncoZenge AB | 2.78M |
| 2cureX AB | 1.98M |